Serstech
10.8.2026 10:30:00 CEST | Globenewswire | Press release
Serstech CFO to leave the company
Serstech CFO to leave the company
Serstech today announces that CFO Simon Persson has decided to leave the company after being offered a CEO position at a non-competing startup. Simon will remain in his role throughout his notice period, until 10 November.
The recruitment process for his successor will commence immediately.
“I would like to thank Simon for his excellent work and for his many valuable contributions to Serstech. We wish him every success in his new role,” says Stefan Sandor, CEO of Serstech.
For further information, please contact:
Stefan Sandor,
CEO, Serstech AB
Phone: +46 739 606 067
Email: ss@serstech.com
or
Arve Nilsson,
Chairman of the Board, Serstech AB
Phone: +45 40 35 82 65
Email: arve.nilsson@serstech.com
or visit: www.serstech.com
Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).
About Serstech
Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden.
Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at www.serstech.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Elemica16.9.2026 14:00:00 CEST | Press release
Elemica® Named a Leader in the 2026 Nucleus Research Control Tower Technology Value Matrix
Apogee Minerals Ltd.16.9.2026 14:00:00 CEST | Press release
Apogee Minerals Closes Knife Lake Copper Project Option Transaction and Files Independent NI 43-101 Technical Report
Novo Nordisk A/S16.9.2026 14:00:00 CEST | Press release
Novo and Anthropic will collaborate to advance drug discovery with Claude
Teva Pharmaceutical Industries Ltd16.9.2026 14:00:00 CEST | Press release
Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care
AAVantgarde16.9.2026 13:00:00 CEST | Press release
AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom